MML Investors Services’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.7M | Buy |
275,171
+9,386
| +4% | +$510K | 0.02% | 581 |
|
|
2026
Q1 | $16.7M | Sell |
265,785
-2,271
| -0.8% | -$182K | 0.05% | 383 |
|
|
2025
Q4 | $25.6M | Buy |
268,056
+83,781
| +45% | +$8.21M | 0.06% | 296 |
|
|
2025
Q3 | $18M | Buy |
184,275
+50,851
| +38% | +$5.27M | 0.05% | 368 |
|
|
2025
Q2 | $14.3M | Buy |
133,424
+7,990
| +6% | +$808K | 0.04% | 405 |
|
|
2025
Q1 | $12.7M | Buy |
125,434
+17,786
| +17% | +$1.79M | 0.04% | 403 |
|
|
2024
Q4 | $9.62M | Buy |
107,648
+18,840
| +21% | +$1.66M | 0.03% | 455 |
|
|
2024
Q3 | $7.44M | Buy |
88,808
+3,771
| +4% | +$297K | 0.03% | 535 |
|
|
2024
Q2 | $6.55M | Sell |
85,037
-3,212
| -4% | -$235K | 0.03% | 546 |
|
|
2024
Q1 | $6.04M | Sell |
88,249
-1,354
| -2% | -$87.1K | 0.02% | 564 |
|
|
2023
Q4 | $5.18M | Buy |
89,603
+7,514
| +9% | +$401K | 0.02% | 581 |
|
|
2023
Q3 | $4.33M | Buy |
82,089
+15,623
| +24% | +$819K | 0.02% | 602 |
|
|
2023
Q2 | $3.6M | Buy |
66,466
+5,011
| +8% | +$262K | 0.02% | 659 |
|
|
2023
Q1 | $3.08M | Sell |
61,455
-1,889
| -3% | -$89K | 0.02% | 622 |
|
|
2022
Q4 | $2.93M | Buy |
63,344
+15,133
| +31% | +$655K | 0.02% | 672 |
|
|
2022
Q3 | $1.87M | Buy |
48,211
+7,528
| +19% | +$302K | 0.01% | 786 |
|
|
2022
Q2 | $1.52M | Buy |
40,683
+5,581
| +16% | +$227K | 0.01% | 862 |
|
|
2022
Q1 | $1.55M | Sell |
35,102
-1,538
| -4% | -$66.7K | 0.01% | 898 |
|
|
2021
Q4 | $1.56M | Buy |
36,640
+2,264
| +7% | +$95.1K | 0.01% | 865 |
|
|
2021
Q3 | $1.49M | Buy |
34,376
+3,331
| +11% | +$147K | 0.01% | 852 |
|
|
2021
Q2 | $1.33M | Sell |
31,045
-2,850
| -8% | -$120K | 0.01% | 883 |
|
|
2021
Q1 | $1.31M | Sell |
33,895
-3,918
| -10% | -$148K | 0.01% | 813 |
|
|
2020
Q4 | $1.36M | Sell |
37,813
-16,351
| -30% | -$589K | 0.01% | 716 |
|
|
2020
Q3 | $2.07M | Buy |
54,164
+4,231
| +8% | +$163K | 0.03% | 514 |
|
|
2020
Q2 | $1.75M | Buy |
49,933
+13,393
| +37% | +$482K | 0.02% | 546 |
|
|
2020
Q1 | $1.19M | Buy |
36,540
+3,007
| +9% | +$117K | 0.02% | 574 |
|
|
2019
Q4 | $1.52M | Sell |
33,533
-3,503
| -9% | -$147K | 0.02% | 568 |
|
|
2019
Q3 | $1.51M | Buy |
37,036
+2,341
| +7% | +$99.2K | 0.02% | 536 |
|
|
2019
Q2 | $1.49M | Buy |
34,695
+7,573
| +28% | +$291K | 0.02% | 582 |
|
|
2019
Q1 | $1.04M | Buy |
27,122
+6,078
| +29% | +$232K | 0.02% | 688 |
|
|
2018
Q4 | $744K | Buy |
21,044
+2,196
| +12% | +$79.6K | 0.01% | 725 |
|
|
2018
Q3 | $726K | Buy |
18,848
+5,047
| +37% | +$176K | 0.01% | 810 |
|
|
2018
Q2 | $451K | Buy |
13,801
+776
| +6% | +$23.4K | 0.01% | 888 |
|
|
2018
Q1 | $356K | Sell |
13,025
-948
| -7% | -$25.8K | 0.01% | 993 |
|
|
2017
Q4 | $346K | Buy |
13,973
+579
| +4% | +$16K | 0.01% | 1025 |
|
|
2017
Q3 | $391K | Buy |
13,394
+135
| +1% | +$3.73K | 0.01% | 891 |
|
|
2017
Q2 | $368K | Buy |
13,259
+2,453
| +23% | +$65.1K | 0.01% | 892 |
|
|
2017
Q1 | $269K | Buy |
+10,806
| New | +$263K | 0.01% | 636 |
|
Other funds holding BSX
MML Investors Services's BSX Position: Q2 2026 in Review
MML Investors Services increased its Boston Scientific (BSX) stake by 3.5% in Q2 2026, buying an estimated $510K and bringing the position to 275,171 shares worth $11.7M. The position accounts for 0.02% of the portfolio, ranked #581.
MML Investors Services first reported a position in BSX in Q1 2017 and has held it in 38 quarters since. The position peaked at $25.6M in Q4 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- MML Investors Services held 275,171 shares of Boston Scientific worth $11.7M as of Q2 2026.
- MML Investors Services bought 9,386 Boston Scientific shares in Q2 2026, an estimated $510K.
- Boston Scientific made up 0.02% of MML Investors Services's portfolio in Q2 2026, its #581 holding.
- MML Investors Services first reported a position in Boston Scientific in Q1 2017 and has held it in 38 quarters since.
- MML Investors Services's Boston Scientific position peaked at $25.6M in Q4 2025.
- 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.